U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
191610191610Imatinib Mesylate in Treating Patients With GliomasCompletedNo Results AvailableBrain and Central Nervous System TumorsDrug: imatinib mesylatehttps://ClinicalTrials.gov/show/NCT00039364
191581191581Massage Therapy for Cancer-Related FatigueCompletedNo Results AvailableBreast Neoplasms|Ovarian Neoplasms|Prostatic Neoplasms|Colorectal NeoplasmsProcedure: Moderate-intensity and low-intensity bodywork therapyhttps://ClinicalTrials.gov/show/NCT00039793
191582191582Evaluation of BNP7787 for the Prevention of Neurotoxicity in Metastatic Breast Cancer Patients Receiving Weekly PaclitaxelActive, not recruitingNo Results AvailableBreast Neoplasms|Breast Diseases|Metastases, NeoplasmDrug: BNP7787|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00039780
191583191583Heparin Versus Lepirudin Flushes in Preventing Blockage of Venous Access DevicesCompletedNo Results AvailableThrombosisDrug: Lepirudinhttps://ClinicalTrials.gov/show/NCT00039767
191584191584A Trial of Skeletal Targeted Radiotherapy Using Holmium-166-DOTMP in Patients With Multiple MyelomaTerminatedNo Results AvailableMultiple MyelomaDrug: Holmium-166-DOTMPhttps://ClinicalTrials.gov/show/NCT00039754
191585191585Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected ChildrenCompletedHas ResultsHIV InfectionsDrug: NRTIs (ABC, FTC, FTC/TDF, 3TC, 3TC/AZT, d4T, TDF, ddC, AZT)|Drug: NNRTIs (EFV, NVP)|Drug: PIs (AMP, IDV, LPV/r, NFV, SQV, RTV)https://ClinicalTrials.gov/show/NCT00039741
191586191586Effects of Hydrocortisone in Patients With Post-Traumatic Stress DisorderCompletedNo Results AvailablePost-Traumatic Stress Disorders|Healthyhttps://ClinicalTrials.gov/show/NCT00039715
191587191587Brain Imaging in Alzheimer's DiseaseCompletedNo Results AvailableAlzheimer DiseaseDrug: [123] 5-I-A-85380https://ClinicalTrials.gov/show/NCT00039702
191588191588Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research Studies on Primary and Chronic HIV-Infected PatientsRecruitingNo Results AvailableHIVhttps://ClinicalTrials.gov/show/NCT00039689
191589191589Clinical, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Hematologic CancerRecruitingNo Results AvailableWaldenstrom Macroglobulinemia|Chronic Lymphocytic Leukemia|Hodgkin Disease|NonHodgkin Lymphoma|Mixed Lymphoproliferative Diseasehttps://ClinicalTrials.gov/show/NCT00039676
191590191590Endothelial Dysfunction as a Risk Factor in HIV StudyCompletedNo Results AvailableHIV InfectionsDrug: Pravastatin|Drug: Gemfibrozil|Drug: Rosiglitazonehttps://ClinicalTrials.gov/show/NCT00039663
191591191591Pilot Study: Effects of G-CSF on T Cell FunctionCompletedNo Results AvailableHealthyhttps://ClinicalTrials.gov/show/NCT00039650
191592191592Magnetic Resonance-Guided High-Dose Brachytherapy (Short-Range Radiation Therapy) for Prostate CancerCompletedNo Results AvailableProstatic NeoplasmsDevice: Nuvo 9000 Endocavitary Prostate Coilhttps://ClinicalTrials.gov/show/NCT00039624
191593191593Combination Chemotherapy in Treating Patients With Advanced Colorectal CancerCompletedNo Results AvailableColorectal CancerDrug: FOLFOX regimen|Drug: fluorouracil|Drug: leucovorin calcium|Drug: oxaliplatinhttps://ClinicalTrials.gov/show/NCT00039611
191594191594Imatinib Mesylate in Treating Patients With Refractory or Relapsed Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer, or Ovarian Low Malignant Potential TumorCompletedNo Results AvailableFallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cavity CancerDrug: imatinib mesylatehttps://ClinicalTrials.gov/show/NCT00039585
191595191595Boron Neutron Capture Therapy in Treating Patients With Glioblastoma Multiforme or Melanoma Metastatic to the BrainCompletedNo Results AvailableBrain and Central Nervous System Tumors|Melanoma (Skin)|Metastatic CancerDrug: boronophenylalanine-fructose complexhttps://ClinicalTrials.gov/show/NCT00039572
191596191596Clinical Trial to Screen Participants Who Are at High Genetic Risk for Ovarian CancerActive, not recruitingNo Results AvailableOvarian CancerOther: Early detectionhttps://ClinicalTrials.gov/show/NCT00039559
191597191597Combination Chemotherapy in Treating Women With Breast Cancer Who Have Undergone SurgeryActive, not recruitingNo Results AvailableBreast CancerDrug: cyclophosphamide|Drug: epirubicin hydrochloride|Drug: gemcitabine hydrochloride|Drug: paclitaxel|Procedure: adjuvant therapyhttps://ClinicalTrials.gov/show/NCT00039546
191598191598Sulindac and Docetaxel in Treating Women With Metastatic or Recurrent Breast CancerCompletedNo Results AvailableBreast CancerDrug: docetaxel|Drug: sulindachttps://ClinicalTrials.gov/show/NCT00039520
191599191599Radiofrequency Ablation During Surgery in Treating Patients With Non-Small Cell Lung CancerCompletedNo Results AvailableLung CancerProcedure: conventional surgery|Procedure: radiofrequency ablationhttps://ClinicalTrials.gov/show/NCT00039507
191600191600Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain TumorsCompletedNo Results AvailableAdult Giant Cell Glioblastoma|Adult Glioblastoma|Adult GliosarcomaDrug: erlotinib hydrochloride|Radiation: 3-dimensional conformal radiation therapy|Drug: temozolomidehttps://ClinicalTrials.gov/show/NCT00039494
191601191601Oblimersen Plus Combination Chemotherapy and Dexrazoxane in Treating Children and Adolescents With Relapsed or Refractory Solid TumorsCompletedNo Results AvailableCardiac Toxicity|Unspecified Childhood Solid Tumor, Protocol SpecificBiological: oblimersen sodium|Drug: dexrazoxane hydrochloride|Drug: doxorubicin hydrochloride|Drug: cyclophosphamide|Biological: filgrastim|Other: laboratory biomarker analysis|Other: pharmacological studyhttps://ClinicalTrials.gov/show/NCT00039481
191602191602Thalidomide and Irinotecan in Treating Patients With Glioblastoma Multiforme Who Have Undergone Radiation TherapyCompletedNo Results AvailableBrain and Central Nervous System TumorsDrug: irinotecan hydrochloride|Drug: thalidomidehttps://ClinicalTrials.gov/show/NCT00039468
191603191603Trastuzumab and Flavopiridol in Treating Patients With Metastatic Breast CancerTerminatedNo Results AvailableHER2-positive Breast Cancer|Male Breast Cancer|Recurrent Breast Cancer|Stage IV Breast CancerBiological: trastuzumab|Drug: alvocidib|Other: laboratory biomarker analysis|Other: pharmacological studyhttps://ClinicalTrials.gov/show/NCT00039455
191604191604Capecitabine in Treating Patients With Persistent or Recurrent Cervical CancerCompletedNo Results AvailableCervical Adenocarcinoma|Cervical Adenosquamous Carcinoma|Recurrent Cervical CarcinomaDrug: Capecitabine|Other: Laboratory Biomarker Analysishttps://ClinicalTrials.gov/show/NCT00039442
191605191605Atrasentan in Treating Patients With Locally Recurrent or Metastatic Kidney CancerCompletedNo Results AvailableKidney CancerDrug: atrasentan hydrochloridehttps://ClinicalTrials.gov/show/NCT00039429
191606191606Imatinib Mesylate in Treating Patients With MyelofibrosisCompletedNo Results AvailableChronic Myelomonocytic Leukemia|Essential Thrombocythemia|Polycythemia Vera|Primary MyelofibrosisDrug: imatinib mesylate|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00039416
191607191607UCN-01 and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic CancerCompletedNo Results AvailableAdenocarcinoma of the Pancreas|Recurrent Pancreatic Cancer|Stage II Pancreatic Cancer|Stage III Pancreatic Cancer|Stage IV Pancreatic CancerDrug: 7-hydroxystaurosporine|Drug: gemcitabine hydrochloride|Other: pharmacological study|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00039403
191608191608Gefitinib and Capecitabine in Treating Patients With Advanced Solid TumorsCompletedNo Results AvailableUnspecified Adult Solid Tumor, Protocol SpecificDrug: capecitabine|Drug: gefitinib|Other: pharmacological study|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00039390
191609191609Chemotherapy, Imatinib Mesylate, and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaCompletedHas ResultsAdult Acute Lymphoblastic Leukemia in RemissionDrug: imatinib mesylate|Drug: methotrexate|Drug: vincristine sulfate|Drug: leucovorin calcium|Procedure: peripheral blood stem cell transplantation|Procedure: autologous hematopoietic stem cell transplantation|Procedure: allogeneic hematopoietic stem cell transplantation|Radiation: total-body irradiation|Drug: tacrolimus|Biological: filgrastim|Drug: etoposide|Drug: cyclophosphamide|Drug: cytarabine|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00039377

* Görseller ve İçerik tekif hakkına sahip olabilir